Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Long-Term Investments (2020 - 2025)

INVO Fertility (IVF) has disclosed Long-Term Investments for 6 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments rose 219.61% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a 219.61% increase, with the full-year FY2024 number at $740759.0, down 19.15% from a year prior.
  • Long-Term Investments was $2.5 million for Q3 2025 at INVO Fertility, roughly flat from $2.5 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.5 million in Q2 2025 to a low of $141267.0 in Q2 2021.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2023 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 1419.04% in 2021, then fell 28.48% in 2024.
  • INVO Fertility's Long-Term Investments stood at $1.5 million in 2021, then dropped by 16.92% to $1.2 million in 2022, then fell by 25.98% to $916248.0 in 2023, then fell by 19.15% to $740759.0 in 2024, then surged by 233.01% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Long-Term Investments are $2.5 million (Q3 2025), $2.5 million (Q2 2025), and $710855.0 (Q1 2025).